Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Capsaicin 0.035 Percent
Generic Name
Capsaicin
Active Ingredient
CapsaicinCategory
Amide Local Anesthetic [EPC]
Variants
2
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| .035 g/100g | CREAM | TOPICAL | 50488-1035 |
| .035 g/100g | PATCH | TOPICAL | 50488-2035 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Capsaicin 0.035 Percent, you must consult a qualified healthcare professional.
Detailed information about Capsaicin 0.035 Percent
Capsaicin is a topical analgesic and Amide Local Anesthetic [EPC] derived from chili peppers, primarily used to manage neuropathic pain and musculoskeletal discomfort by desensitizing sensory neurons.
Dosage for Capsaicin varies significantly based on the concentration of the product and the condition being treated. For over-the-counter (OTC) preparations (creams, gels, or lotions containing 0.025% to 0.1% Capsaicin), the standard recommendation is to apply a thin layer to the affected area 3 to 4 times daily. It is critical to note that the analgesic effect of low-dose Capsaicin is cumulative; it may take 2 to 4 weeks of consistent daily use before the full benefit is realized. Patients should not use these products 'as needed' but rather on a regular schedule.
For the prescription-strength 8% patch (Qutenza), the dosage is a single 60-minute application (for postherpetic neuralgia) or a 30-minute application (for diabetic peripheral neuropathy of the feet). This procedure is performed by a healthcare professional and can be repeated every 90 days if the pain returns. The patch is applied to the most painful areas of the skin, which are mapped out by the clinician prior to application.
Capsaicin is generally not recommended for use in children under the age of 18. There is limited clinical data regarding the safety and efficacy of Capsaicin in pediatric populations. Children have thinner skin and may be more susceptible to the intense burning sensation and potential skin irritation associated with the drug. If a healthcare provider determines that Capsaicin is necessary for a pediatric patient, it must be used under strict medical supervision.
Because Capsaicin is applied topically and systemic absorption is negligible, no specific dosage adjustments are required for patients with mild to moderate renal impairment. However, patients with end-stage renal disease (ESRD) should be monitored closely if using high-concentration patches.
No dosage adjustments are typically necessary for patients with hepatic (liver) impairment. The rapid metabolism of any absorbed Capsaicin by the liver means that even in cases of reduced liver function, the systemic levels remain low enough to avoid toxicity in most patients.
Elderly patients (aged 65 and older) can generally use Capsaicin at the same dosage as younger adults. However, clinicians should assess the integrity of the patient's skin before application, as older skin may be more fragile and prone to irritation or breakdown.
When using OTC Capsaicin, follow these specific instructions to ensure safety and effectiveness:
If you miss a dose of OTC Capsaicin, apply it as soon as you remember. If it is almost time for your next scheduled application, skip the missed dose and resume your regular schedule. Do not 'double up' on the amount of cream to make up for a missed dose, as this significantly increases the risk of severe skin irritation.
Since Capsaicin is topical, a systemic overdose is highly unlikely. However, 'over-application' to the skin can cause severe redness, blistering, or intense pain. If the medication is accidentally swallowed, seek emergency medical attention or contact a Poison Control Center immediately. Symptoms of ingestion may include severe abdominal pain, nausea, vomiting, and diarrhea. If Capsaicin gets into the eyes, flush them immediately with large amounts of cool water for at least 15 minutes.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or frequency of application without medical guidance. If the pain does not improve within 7 days of consistent use, consult your doctor.
The most frequently reported side effect of Capsaicin is a localized skin reaction at the site of application. Because Capsaicin works by stimulating pain receptors, most patients will experience some degree of:
These symptoms are generally mild to moderate and tend to resolve within a few hours to a few days of continued use. If the burning is unbearable, you may try applying a cold pack to the area or using a mild topical anesthetic like lidocaine, but only after consulting your healthcare provider.
Capsaicin is a potent substance that must be handled with extreme care. The primary safety concern is the risk of accidental contact with mucous membranes (eyes, nose, mouth) or sensitive skin. Patients must be educated on the importance of hand hygiene and the avoidance of heat in the treated area. Heat, such as from heating pads, hot tubs, or even intense sunlight, can significantly increase the absorption of Capsaicin, potentially leading to severe burns or systemic toxicity. Furthermore, Capsaicin should never be applied to skin that is broken, infected, or has an active rash, as this bypasses the skin's natural protective barrier.
No FDA black box warnings for Capsaicin. While it is a powerful medication, it does not carry the highest level of FDA warning typically reserved for drugs with life-threatening risks under normal use conditions.
There are no documented 'absolute' drug-drug contraindications where Capsaicin must never be used with another systemic medication. However, it should not be used simultaneously with other topical pain relievers (such as lidocaine or diclofenac creams) on the same area of skin unless specifically directed by a doctor. Combining topical agents can alter the absorption of both drugs and increase the risk of severe skin irritation or a chemical burn.
Capsaicin must NEVER be used in the following circumstances:
Capsaicin is classified by the FDA as Pregnancy Category B (for some formulations) or Category C (for others, like the 8% patch). This means that animal studies have either not shown a risk to the fetus or have shown some risk, but there are no adequate and well-controlled studies in pregnant women. Because systemic absorption of topical Capsaicin is very low, the risk to the developing fetus is generally considered to be minimal. However, it should only be used during pregnancy if the potential benefit justifies the potential risk. There is no evidence of teratogenicity (causing birth defects) at standard human doses. Use during the third trimester is generally avoided if possible to prevent any potential stress to the mother from the burning sensation.
It is not known whether Capsaicin is excreted in human breast milk. However, given the minimal systemic absorption after topical application, it is unlikely that significant amounts would reach the infant through breastfeeding. The primary concern is 'accidental transfer.' If a nursing mother applies Capsaicin to her chest or hands, the infant could come into direct contact with the medication, leading to severe skin or eye irritation. If you are breastfeeding, avoid applying Capsaicin to the breast area and wash your hands meticulously before handling your baby.
Capsaicin is a potent and highly selective agonist of the Transient Receptor Potential Vanilloid 1 (TRPV1) receptor, formerly known as the vanilloid receptor 1 (VR1). TRPV1 is a non-selective cation channel predominantly expressed on the peripheral terminals of primary afferent nociceptors (pain-sensing neurons).
Upon binding to the TRPV1 receptor, Capsaicin induces an initial excitation of the neuron, characterized by an influx of calcium (Ca2+) and sodium (Na+) ions. This depolarization leads to the release of pro-inflammatory neuropeptides, most notably Substance P and Calcitonin Gene-Related Peptide (CGRP). This is the 'burning' phase. However, the therapeutic effect is achieved through 'defunctionalization.' The massive influx of calcium triggers calcium-activated proteases and causes the cytoskeleton of the nerve ending to break down. This results in a temporary loss of the nerve terminal's function and a depletion of Substance P. Without Substance P, the nerve cannot transmit pain signals to the spinal cord and brain. This state of 'desensitization' can last for weeks or months until the nerve endings regenerate.
The pharmacodynamics of Capsaicin are characterized by a clear dose-response relationship. Low concentrations (0.025%) require frequent application to maintain Substance P depletion, while high concentrations (8%) can achieve long-lasting defunctionalization with a single application. The onset of the burning sensation is immediate (within minutes), but the onset of pain relief is delayed, often taking 1 to 2 weeks for OTC products. The duration of effect for the 8% patch is typically 12 weeks.
Common questions about Capsaicin 0.035 Percent
Capsaicin is primarily used to relieve various types of pain, including nerve pain (neuropathy), muscle aches, and joint discomfort. It is FDA-approved for treating postherpetic neuralgia (pain after shingles) and diabetic nerve pain in the feet. Additionally, it is commonly found in over-the-counter creams for arthritis and simple backaches. By targeting specific pain receptors on the skin, it helps to desensitize them over time. Your healthcare provider may also recommend it for other chronic pain conditions that have not responded to oral medications.
The most common side effects are localized to the area where the medication is applied. These include a strong sensation of burning, stinging, or heat, along with redness and occasional itching. These symptoms are usually most intense during the first few days of treatment and tend to decrease as your nerves become used to the medication. Some people may also experience mild swelling or dry skin at the application site. If these effects are severe or do not improve, you should contact your healthcare provider for advice on managing the discomfort.
There is no direct drug interaction between alcohol and topical Capsaicin. However, alcohol can cause your blood vessels to dilate (widen), which might increase the blood flow to your skin and make the burning sensation from the Capsaicin feel more intense. For some people, alcohol can also increase skin sensitivity or flushing. It is generally safe to consume alcohol in moderation, but be aware of how it might affect your skin's reaction to the treatment. Always discuss your lifestyle habits with your doctor when starting a new pain management regimen.
Capsaicin is generally considered to have low risk during pregnancy because very little of the drug is absorbed into the bloodstream from the skin. However, there are no definitive clinical trials in pregnant women to guarantee absolute safety. It should only be used if your healthcare provider determines that the benefits clearly outweigh any potential risks. Most doctors recommend avoiding high-concentration patches during pregnancy unless necessary. If you are pregnant or planning to become pregnant, talk to your doctor before using any Capsaicin-containing products.
The time it takes for Capsaicin to provide pain relief depends on the strength of the product and how consistently it is used. For over-the-counter creams, you may need to apply the medication 3 to 4 times daily for 2 to 4 weeks before you notice a significant reduction in pain. This is because the medication needs time to deplete the 'Substance P' in your nerves. For the high-concentration 8% prescription patch, some relief may be felt within a few days, with the full effect peaking a few weeks after the procedure. Consistency is key to the success of this treatment.
Yes, you can stop using topical Capsaicin suddenly without experiencing withdrawal symptoms or physical 'rebound' effects. Unlike some oral pain medications, Capsaicin does not cause physical dependence. However, once you stop using it, the 'Substance P' in your nerves will eventually replenish, and your original pain may return within a few days or weeks. If you are stopping because of side effects, your doctor can help you find an alternative treatment. Always inform your healthcare provider if you decide to discontinue a prescribed treatment plan.
If you miss a dose of over-the-counter Capsaicin cream, apply it as soon as you remember. However, if it is almost time for your next scheduled application, it is better to skip the missed dose and stay on your regular schedule. Do not apply extra cream to 'make up' for the missed dose, as this can lead to severe skin irritation. For the prescription 8% patch, the treatment is administered by a professional every 90 days, so 'missing a dose' would involve missing your appointment. If that happens, reschedule with your clinic as soon as possible.
There is no clinical evidence to suggest that topical Capsaicin causes weight gain. Because the medication is applied to the skin and very little enters the systemic circulation, it does not affect your metabolism, appetite, or hormones in a way that would lead to weight changes. In fact, some laboratory studies on oral Capsaicin (found in spicy peppers) have explored its potential to *increase* metabolism, but these effects are not seen with topical pain relief products. If you experience unexpected weight gain while using Capsaicin, it is likely due to other factors and should be discussed with your doctor.
Capsaicin can usually be used alongside most oral medications, but you should be cautious when using other topical products. Applying multiple creams or patches to the same area of skin can cause severe irritation or change how the medications are absorbed. There is also a known minor interaction with ACE inhibitors (blood pressure drugs), which may increase the risk of a dry cough. Always provide your healthcare provider with a complete list of all medications, including vitamins and herbal supplements, to ensure there are no conflicting treatments.
Yes, Capsaicin is widely available as a generic medication in various over-the-counter forms, including creams, gels, and lotions. These generic versions are typically much less expensive than brand-name products but contain the same active ingredient. The high-concentration 8% patch (Qutenza) is currently a brand-name specialty product and may not have a generic equivalent available in all regions. When purchasing over-the-counter, look for the 'Capsaicin' name on the active ingredients list to ensure you are getting the correct medication.
Other drugs with the same active ingredient (Capsaicin)
Some patients may experience more pronounced reactions, including:
Rarely, patients may experience systemic or severe local reactions:
While Capsaicin is generally safe when used as directed, certain symptoms require immediate medical intervention. Stop using the product and call your doctor if you experience:
> Warning: Stop taking Capsaicin and call your doctor immediately if you experience any signs of a severe allergic reaction, such as hives, swelling of the face or throat, or extreme dizziness.
Long-term use of Capsaicin is generally considered safe for the skin. However, there is a theoretical concern regarding 'sensory loss.' Because Capsaicin causes a temporary retraction of nerve endings, prolonged use could lead to a persistent decrease in the ability to feel certain types of pain or temperature in the treated area. Clinical studies on the 8% patch have shown that nerve fibers typically regrow within a few months of stopping treatment, and no permanent loss of sensation has been documented in most patients. Nevertheless, patients with existing sensory deficits (like those with advanced diabetes) should be monitored closely for any worsening of their condition.
There are currently no FDA Black Box Warnings for Capsaicin. However, the FDA requires strict 'Warnings and Precautions' for the 8% patch regarding the risk of severe irritation and the necessity of application by healthcare professionals. The labeling emphasizes that the patch must not be handled by the patient and that the treatment area must be handled with caution to avoid accidental transfer of the drug to other parts of the body.
Report any unusual symptoms or persistent irritation to your healthcare provider. It is helpful to keep a 'pain and side effect' diary to discuss with your doctor during follow-up appointments.
For standard OTC use, specialized lab tests are not typically required. However, for patients receiving the 8% prescription patch, healthcare providers should monitor:
Capsaicin does not typically cause drowsiness or cognitive impairment. Most patients can safely drive or operate machinery after application. However, if you are experiencing significant pain or distress from the burning sensation, it is advisable to wait until the discomfort subsides before engaging in activities that require full concentration.
There are no known direct interactions between topical Capsaicin and alcohol. However, alcohol can cause vasodilation (widening of blood vessels), which might theoretically increase the intensity of the burning sensation or redness at the application site. It is generally best to use alcohol in moderation while using any medication for chronic pain.
Unlike some oral pain medications (like opioids or gabapentinoids), Capsaicin does not cause physical dependence or a withdrawal syndrome. You can stop using OTC Capsaicin at any time without tapering. However, your pain may return once the medication's effect wears off. If you are using the 8% patch, the effects naturally fade over 3 months, at which point your doctor will determine if another application is necessary.
> Important: Discuss all your medical conditions, including any history of high blood pressure or respiratory issues, with your healthcare provider before starting Capsaicin.
Capsaicin is not known to interfere with common laboratory tests, such as blood counts, liver function tests, or urinalysis. It does not typically show up on standard drug screenings for employment or athletics.
For each major interaction, the primary mechanism is usually pharmacodynamic (affecting how the body responds to the drug) rather than pharmacokinetic (affecting how the body processes the drug). The management strategy usually involves staggering the application of topical products or monitoring for increased side effects.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, even if they are 'natural' or applied to the skin.
Conditions requiring a careful risk-benefit analysis by a healthcare provider include:
Patients who are allergic to hot peppers (Capsicum family) are highly likely to be allergic to Capsaicin. There is also a potential for cross-sensitivity with other members of the Solanaceae (nightshade) family, such as tomatoes, potatoes, or eggplant, although this is much less common. If you have experienced a skin rash or swelling after handling these foods, inform your doctor before using Capsaicin.
> Important: Your healthcare provider will evaluate your complete medical history and perform a skin assessment before prescribing or recommending Capsaicin. Always report any history of 'sensitive skin' or previous reactions to topical products.
As previously noted, the safety and effectiveness of Capsaicin in pediatric patients (under 18 years of age) have not been established. The risk of severe skin irritation and the difficulty in managing the 'burning' sensation in children make it a second- or third-line option at best. For children, healthcare providers usually explore other topical options like lidocaine or systemic treatments first.
Clinical studies of Capsaicin included a significant number of patients aged 65 and older. No overall differences in safety or effectiveness were observed between these patients and younger subjects. However, elderly patients are more likely to have thinner skin and a higher prevalence of peripheral vascular disease, which may increase the risk of skin breakdown. Additionally, elderly patients on multiple medications (polypharmacy) should be monitored for any interactions with blood pressure medications.
No specific dose adjustments are recommended for patients with renal impairment. The kidneys eliminate only the small fraction of Capsaicin that is absorbed systemically. In patients on dialysis, the 8% patch has not been specifically studied, but it is unlikely to pose a significant risk due to the localized nature of the treatment.
In patients with mild to moderate hepatic impairment (Child-Pugh Class A or B), no dose adjustment is necessary. The liver's capacity to metabolize Capsaicin is vast, and the tiny amounts absorbed from the skin are easily processed. For patients with severe hepatic impairment, use should be monitored, but topical application remains generally safe.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or are currently breastfeeding before starting any new medication.
| Parameter | Value |
|---|---|
| Bioavailability | <1% (Topical) |
| Protein Binding | High (Estimated >90%) |
| Half-life | 1.5 - 2.0 hours (Systemic) |
| Tmax | 60 minutes (for 8% patch) |
| Metabolism | Hepatic (CYP1A2, CYP2E1) |
| Excretion | Renal (>70%), Fecal (minor) |
Capsaicin is classified as an Amide Local Anesthetic [EPC] and a Topical Analgesic. While it shares the 'amide' structure with local anesthetics like lidocaine, its mechanism (TRPV1 agonism) is distinct from the sodium-channel blocking action of traditional anesthetics. It is also categorized as a 'Counter-irritant' in many OTC monographs because it creates a sensation that 'counters' the underlying pain.